Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition | Circulation
sacubitril | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
Frontiers | Neprilysin Inhibitors and Bradykinin
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure | NEJM
SACUBITRIL
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition. - Abstract - Europe PMC
Sacubitril - Wikipedia
Sacubitril - Wikipedia
Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy | Circulation: Heart Failure
Sacubitril calcium | AHU377 | LCZ696 | CAS#149709-62-6 | 1369773-39-6 | 149690-05-1 |angiotensin receptor neprilysin inhibitor | MedKoo Biosciences
Sacubitril | New Drug Approvals
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
Heart failure with preserved ejection fraction: emerging drug strategies. - Abstract - Europe PMC
Entresto | C96H120N12Na6O21 | CID 71449007 - PubChem
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
Bio <-> Chem: Back-story on Novartis LCZ696 database links
PharmaWiki - Sacubitril
File:Valsartan.svg - Wikipedia
Sacubitril | New Drug Approvals
Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy | Circulation: Heart Failure
Sacubitril – Wikipedia
Bio <-> Chem: Back-story on Novartis LCZ696 database links
Neprilysin - Wikipedia
